Displaying drugs 2001 - 2025 of 2774 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Doravirine | 425.749 C17H11ClF3N5O3 |  | A non-nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals to treat HIV-1 infections. | Non-Nucleoside Reverse Transcriptase Inhibitors |
| Domperidone | 425.911 C22H24ClN5O2 |  | A dopamine receptor antagonist used as a peristaltic stimulant and anti-emetic agent for dyspepsia, indigestion, epigastric pain, nausea, and vomiting. | Propulsives |
| Vericiguat | 426.388 C19H16F2N8O2 |  | A soluble guanylate cyclase stimulator used to reduce heart failure-related hospitalization and cardiovascular death in patients with chronic systolic heart failure. | Soluble Guanylate Cyclase Stimulator |
| Iloperidone | 426.4806 C24H27FN2O4 |  | An atypical antipsychotic agent used to treat schizophrenia and manic or mixed episodes associated with bipolar I disorder in adults. | Agents that produce hypertension / Neurotoxic agents |
| Paliperidone | 426.4839 C23H27FN4O3 |  | An atypical antipsychotic used in the treatment of schizophrenia and other schizoaffective or delusional disorders. | Agents that produce hypertension / Neurotoxic agents |
| Darifenacin | 426.55 C28H30N2O2 |  | An M3 muscarinic receptor blocker used to treat urinary incontinence. | Drugs for Urinary Frequency and Incontinence |
| Oxatomide | 426.564 C27H30N4O |  | An antihistamine indicated in the treatment and prevention of allergic symptoms. | Piperazine Derivatives |
| Lenvatinib | 426.86 C21H19ClN4O4 |  | A receptor tyrosine kinase inhibitor used for the treatment of metastatic thyroid cancer, advanced renal cell carcinoma in combination with everolimus, and unresectable hepatocellular carcinoma. | Protein Kinase Inhibitors |
| Etofamide | 427.28 C19H20Cl2N2O5 |  | Etofamide is used as an antiamoebic agent. Etofamide, under the brand name Kitnos, was marketed in Brazil by Pfizer but has been discontinued . | Dichloroacetamide Derivatives |
| Ioflupane I-123 | 427.291 C18H23FINO2 |  | A radiopharmaceutical used in single photon emission computed tomography (SPECT) brain imaging to help diagnose patients with suspected Parkinsonian syndromes. | Iodine (123I) Compounds |
| Cariprazine | 427.41 C21H32Cl2N4O |  | An atypical antipsychotic used to treat schizophrenia and acute manic or mixed episodes due to bipolar I disorder. | Agents that produce hypertension / Neurotoxic agents |
| Pemetrexed | 427.4106 C20H21N5O6 |  | A folate analog used to treat mesothelioma and non-small cell lung cancer. | Folic Acid Analogues |
| Cefoxitin | 427.452 C16H17N3O7S2 |  | A semi-synthetic, broad-spectrum antibiotic for parenteral administration used for the treatment of serious bacterial infections, such as urinary tract infection, blood infection, bone and joint infection, and lower respiratory tract infection. | Anti-Bacterial Agents / Second-Generation Cephalosporins |
| Cefpodoxime | 427.455 C15H17N5O6S2 |  | A third-generation cephalosporin antibiotic used in the treatment of various bacterial infections, including gonorrhea, community acquired pneumonia, and sinusitis. | beta Lactam Antibiotics |
| Moricizine | 427.517 C22H25N3O4S |  | An antiarrhythmic used to treat arrhythmias. | Neurotoxic agents |
| Ranolazine | 427.5365 C24H33N3O4 |  | An anti-anginal drug used for the treatment of chronic angina. | Antianginal Agents / Cardiovascular Agents / Piperazines / Sodium Channel Blockers |
| Pimavanserin | 427.564 C25H34FN3O2 |  | A second generation atypical antipsychotic used for the treatment of hallucinations and delusions caused by Parkinson's Disease. | Neurotoxic agents |
| Larotrectinib | 428.444 C21H22F2N6O2 |  | A kinase inhibitor used to treat solid tumors with neurotrophic receptor tyrosine kinase gene fusion, are metastatic, high risk for surgery, or have no alternative treatments. | Protein Kinase Inhibitors |
| Irbesartan | 428.5294 C25H28N6O |  | An angiotensin receptor blocker used to treat hypertension, delay progression of diabetic nephropathy, and treat congestive heart failure. | Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics |
| Umeclidinium | 428.595 C29H34NO2 |  | A long-acting muscarinic antagonist used as a long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). | Agents producing tachycardia |
| Hydroxyprogesterone caproate | 428.6041 C27H40O4 |  | A synthetic progestin used for the prevention of spontaneous preterm births in singleton pregnancies in women who have previously had a spontaneous preterm birth. | Antineoplastic Agents / Estrogen Antagonists / Progestins |
| Triheptanoin | 428.61 C24H44O6 |  | Triheptanoin is a medium chain triglyceride indicated to provide calories and fatty acids to treat long chain fatty acid oxidation disorders. | Various Alimentary Tract and Metabolism Products |
| Nandrolone decanoate | 428.6472 C28H44O3 |  | An anabolic steroid indicated for the management of the anemia of renal insufficiency by increasing hemoglobin and red cell mass. | Anabolic Agents / Androgens / Bone Density Conservation Agents / Nandrolone and esters |
| Ulobetasol | 428.9 C22H27ClF2O4 |  | A lipocortin corticosteroid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses. | Corticosteroids, Potent (Group III) |
| Capivasertib | 428.915 C21H25ClN6O2 |  | A serine/threonine kinase inhibitor used to treat hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer | Proto-Oncogene Proteins c-akt, antagonists & inhibitors |
Displaying drugs 2001 - 2025 of 2774 in total